Cargando…

Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease—A Phase II Study

The efficacy and the safety of the administration of multipotent mesenchymal stromal cells (MMSCs) for acute graft-versus-host disease (aGVHD) prophylaxis following allogeneic hematopoietic cell transplantation (HSCT) were studied. This prospective clinical trial was based on the random patient allo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuzmina, Larisa A., Petinati, Natalia A., Parovichnikova, Elena N., Lubimova, Lidia S., Gribanova, Elena O., Gaponova, Tatjana V., Shipounova, Irina N., Zhironkina, Oxana A., Bigildeev, Alexey E., Svinareva, Daria A., Drize, Nina J., Savchenko, Valery G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253492/ https://www.ncbi.nlm.nih.gov/pubmed/22242033 http://dx.doi.org/10.1155/2012/968213

Ejemplares similares

Immunophenotypic characteristics of multipotent mesenchymal stromal cells that affect the efficacy of their use in the prevention of acute graft vs host disease
por: Petinati, Nataliya, et al.
Publicado: (2020)

Recovery of Donor Hematopoiesis after Graft Failure and Second Hematopoietic Stem Cell Transplantation with Intraosseous Administration of Mesenchymal Stromal Cells
por: Petinati, Nataliya, et al.
Publicado: (2018)

PB1780: DIFFERENCES IN SECRETOME OF BONE MARROW MULTIPOTENT MESENCHYMAL STROMAL CELLS IN PATIENTS AT THE ONSET OF ACUTE MYELOID LEUKEMIA AND AFTER ACHIEVING REMISSION.
por: Sadovskaya, Aleksandra, et al.
Publicado: (2023)

Acute Myeloid Leukemia Causes Serious and Partially Irreversible Changes in Secretomes of Bone Marrow Multipotent Mesenchymal Stromal Cells
por: Sadovskaya, Aleksandra, et al.
Publicado: (2023)

Multipotent Mesenchymal Stromal Cells from Porcine Bone Marrow, Implanted under the Kidney Capsule, form an Ectopic Focus Containing Bone, Hematopoietic Stromal Microenvironment, and Muscles
por: Petinati, Nataliya, et al.
Publicado: (2023)

What do we know about the participation of hematopoietic stem cells in hematopoiesis?
por: Drize, Nina, et al.
Publicado: (2015)

Hematopoiesis during Ontogenesis, Adult Life, and Aging
por: Belyavsky, Alexander, et al.
Publicado: (2021)

P767: COMPARISON OF PROLIFERATIVE, DIFFERENTIATION POTENTIAL AND GENE EXPRESSION IN MULTIPOTENT MESENCHYMAL STROMAL CELLS OF PATIENTS WITH NON-SEVERE AND SEVERE APLASTIC ANEMIA IN THE DEBUT
por: Dorofeeva, Alena, et al.
Publicado: (2023)

Post-engraftment Bloodstream Infections After Allogeneic Hematopoietic Cell Transplantation: Risk Factors and Association with Mortality
por: Akhmedov, Mobil, et al.
Publicado: (2023)

ABCL-093: The Single-Center Analysis of Survival and Mortality in Patients with Hematological Diseases and COVID-19 in Russia
por: Gavrilina, Olga, et al.
Publicado: (2020)

PB2174: ON THE ROBUSTNESS OF THE BUCCAL EPITHELIUM FOR ASSESSING RECIPIENT DNA PROFILE IN PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Risinskaya, N., et al.
Publicado: (2022)

PB1866: IS ALLO-HSCT IN CR1 NECESSARY FOR AML PATIENTS WITH MRD NEGATIVITY ACHIEVED AFTER THE FIRST INDUCTION COURSE? RUSSIAN PROSPECTIVE MULTICENTER RANDOMIZED TRIAL IN AML PATIENTS UNDER THE AGE OF 60
por: Parovichnikova, Elena, et al.
Publicado: (2023)

Outcomes in Patients with Hematologic Disease and COVID-19 in Russia: Interim Analysis of CHRONOS19 Registry
por: Gavrilina, Olga A., et al.
Publicado: (2020)

P566: RESULTS OF NON-CHEMOTERAPEUTIC TREATMENT OF PATIENTS WITH DE NOVO ACUTE PROMYELOCYTIC LEUKEMIA
por: Troitskaya, Vera, et al.
Publicado: (2023)

P1271: THE IMPACT OF CYTOMEGALOVIRUS-SPECIFIC T CELLS USAGE AS ADOPTIVE THERAPY IN PATIENTS WITH PT-CY AND TCR ΑΒ+/CD19+ CELLS DEPLETION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Dmitrova, Anna, et al.
Publicado: (2023)

Mild Hypoxia Enhances Proliferation and Multipotency of Human Neural Stem Cells
por: Santilli, Guido, et al.
Publicado: (2010)

P1334: THE IMPACT OF IMMUNOSUPPRESSION ON RECONSTITUTION OF CMV-SPECIFIC T CELLS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Dmitrova, A., et al.
Publicado: (2022)

Osteoclasts Differentiation from Murine RAW 264.7 Cells Stimulated by RANKL: Timing and Behavior
por: Lampiasi, Nadia, et al.
Publicado: (2021)

Regulation of Immunity via Multipotent Mesenchymal Stromal Cells
por: Rubtsov, Y. P., et al.
Publicado: (2012)

Magnetocontrollability of Fe(7)C(3)@C superparamagnetic nanoparticles in living cells
por: Alieva, Irina B., et al.
Publicado: (2016)

Behavior of Transplanted Multipotent Cells after in Vitro Transplantation into the Damaged Retina
por: Sergeev, S.A., et al.
Publicado: (2011)

Long-term live cells observation of internalized fluorescent Fe@C nanoparticles in constant magnetic field
por: Garanina, Anastasiia, et al.
Publicado: (2019)

The mammary stem cell conundrum: is it unipotent or multipotent?
por: Joshi, Purna A, et al.
Publicado: (2012)

Identification of a Candidate Proteomic Signature to Discriminate Multipotent and Non-Multipotent Stromal Cells
por: Rosu-Myles, Michael, et al.
Publicado: (2012)

Fiber-Like Organization as a Basic Principle for Euchromatin Higher-Order Structure
por: Zakirov, Amir N., et al.
Publicado: (2022)

Regulation of haematopoietic multipotency by EZH1
por: Vo, Linda T., et al.
Publicado: (2018)

PB2480: LENTIVIRAL LABELING OF STROMAL LAYER OF LONG-TERM BONE MARROW CULTURE DEMONSTRATED INEFFICIENCY FOR MESENCHYMAL STEM CELLS AND CONTRIBUTION OF NON-STEM CELLS TO HEMATOPOIETIC ECTOPIC FOCUS IN MICE
por: Karpenko, Dmitriy, et al.
Publicado: (2023)

Multipotency of mouse trophoblast stem cells
por: Hou, Minmin, et al.
Publicado: (2020)

Functional Heterogeneity of Protein Kinase A Activation in Multipotent Stromal Cells
por: Tyurin-Kuzmin, Pyotr A., et al.
Publicado: (2020)

Dual miRNases for Triple Incision of miRNA Target: Design Concept and Catalytic Performance
por: Patutina, Olga, et al.
Publicado: (2020)

P794: DIFFERENTIATION POTENTIAL AND RELATIVE GENE EXPRESSION LEVELS ARE CHANGED IN CFU-F FROM BONE MARROW OF APLASTIC ANEMIA PATIENTS AT THE ONSET OF THE DISEASE
por: Dorofeeva, A., et al.
Publicado: (2022)

Early chromatin shaping predetermines multipotent vagal neural crest into neural, neuronal and mesenchymal lineages
por: Ling, Irving TC, et al.
Publicado: (2019)

Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate
por: Grover, Amit, et al.
Publicado: (2014)

ACSA‐2 and GLAST classify subpopulations of multipotent and glial‐restricted cerebellar precursors
por: Kantzer, Christina Geraldine, et al.
Publicado: (2021)

Chelidonic Acid and Its Derivatives from Saussurea Controversa: Isolation, Structural Elucidation and Influence on the Osteogenic Differentiation of Multipotent Mesenchymal Stromal Cells In Vitro
por: Avdeeva, Elena, et al.
Publicado: (2019)

Some Special Aspects of Liver Repair after Resection and Administration of Multipotent Stromal Cells in Experiment
por: Maiborodin, Igor, et al.
Publicado: (2021)

Site-Selective Artificial Ribonucleases: Renaissance of Oligonucleotide Conjugates for Irreversible Cleavage of RNA Sequences
por: Staroseletz, Yaroslav, et al.
Publicado: (2021)

Bulge-Forming miRNases Cleave Oncogenic miRNAs at the Central Loop Region in a Sequence-Specific Manner
por: Patutina, Olga, et al.
Publicado: (2022)

Sulfated Glycopeptide Nanostructures for Multipotent Protein Activation
por: Lee, Sungsoo S., et al.
Publicado: (2017)

Butylated Hydroxytoluene Analogs: Synthesis and Evaluation of Their Multipotent Antioxidant Activities
por: Yehye, Wageeh A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6mkcm5qmhuvhlj6b18ruoig096